Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
52.63-2.97 (-5.34%)
At close: 04:00PM EDT
52.63 0.00 (0.00%)
After hours: 04:32PM EDT
Advertisement
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts16161617
Avg. Estimate-1.3-1.87-7.45-6.88
Low Estimate-3.04-2.34-9.76-8.86
High Estimate4.84-0.76-0.76-4.48
Year Ago EPS-1.08-1.79-6.7-7.45
Revenue EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts13131317
Avg. Estimate95.11M105.61M372.54M436.03M
Low Estimate81.6M87M354.77M302.8M
High Estimate118M147M433M747.57M
Year Ago Sales81.65M83.39M351.41M372.54M
Sales Growth (year/est)16.50%26.60%6.00%17.00%
Earnings History9/29/202112/30/20213/30/20226/29/2022
EPS Est.-1.41-1.34-1.76-1.75
EPS Actual-1.08-1.79-2.19-2.26
Difference0.33-0.45-0.43-0.51
Surprise %23.40%-33.60%-24.40%-29.10%
EPS TrendCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Current Estimate-1.3-1.87-7.45-6.88
7 Days Ago-1.86-1.67-7.38-6.19
30 Days Ago-1.71-1.64-7.21-5.77
60 Days Ago-1.71-1.64-7.2-5.62
90 Days Ago-1.7-1.53-6.55-4.77
EPS RevisionsCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Up Last 7 Days6243
Up Last 30 Days7344
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days2764
Growth EstimatesRAREIndustrySector(s)S&P 500
Current Qtr.-20.40%N/AN/AN/A
Next Qtr.-4.50%N/AN/AN/A
Current Year-11.20%N/AN/AN/A
Next Year7.70%N/AN/AN/A
Next 5 Years (per annum)-87.60%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A
Advertisement
Advertisement